300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Art
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Real Estate
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Sporting Goods
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Japan
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science Angel Investors in United Kingdom (October 2026)

The most active angel investors investing in United Kingdom Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in United Kingdom Life Science startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Jonathan Milner
Angel
11 United Kingdom, United States, Spain Seed, Series A, Series B Biotechnology, Health Care, Medical $537k–$56M
Nadav Rosenberg
Angel
5 United Kingdom, France, Israel Seed, Pre-Seed, Series A Software, Biotechnology, Artificial Intelligence $1.1M–$21M
Jeff Dean
Angel
3 United States, United Kingdom, Germany Seed, Series A, Pre-Seed Artificial Intelligence, Software, Information Technology $500k–$60M
Stefano Bernardi
Angel
3 Italy, United Kingdom, Canada Seed, Pre-Seed Blockchain, Software, Biotechnology $100k–$18M
Jude Gomila
Angel
3 United States, United Kingdom, India Seed, Pre-Seed, Angel Software, Information Technology, Artificial Intelligence $70k–$4.7M
Charlie Songhurst
Angel
2 United States, United Kingdom, Germany Seed, Pre-Seed, Series A Software, Artificial Intelligence, Information Technology $500k–$24M
Jan Hruska
Angel
2 United Kingdom Seed, Venture - Series Unknown Medical, Health Care, Life Science
Matt Clifford
Angel
2 United Kingdom, United States, India Seed, Pre-Seed, Venture - Series Unknown Software, Artificial Intelligence, FinTech $55k–$34M
Paul Forster
Angel
2 United Kingdom, Germany, United States Seed, Series A, Pre-Seed Software, FinTech, Financial Services $1M–$26M
Robert Kopple
Angel
2 United States, United Kingdom Convertible Note, Venture - Series Unknown FinTech, Finance, Life Science $3.3M–$4.8M
Bradley Horowitz
Angel
2 United States, United Kingdom, Germany Seed, Series A, Pre-Seed Software, Artificial Intelligence, Information Technology $150k–$36M
Paul Wicks
Angel
2 United Kingdom, United States, Japan Seed, Pre-Seed, Series A Software, Wellness, E-Commerce $539k–$11M
Mark Evans
Angel
2 United Kingdom, United States, The Netherlands Series A, Seed, Series C Retail, Fashion, Software $1.4M–$68M
Damien Lane
Angel
2 United Kingdom, United States, Ireland Seed, Pre-Seed, Series A Software, SaaS, Health Care $532k–$16M
Nicholas Edwards
Angel
2 United Kingdom Seed, Venture - Series Unknown Medical, Health Care, Life Science
Darrin Disley
Angel
2 United Kingdom Seed, Series A, Venture - Series Unknown Biotechnology, Health Care, Big Data $462k–$3.7M
Ian Hogarth
Angel
2 United Kingdom, United States, Germany Seed, Pre-Seed, Series A Software, Artificial Intelligence, SaaS $698k–$43M
Tim Davis
Angel
2 United States, United Kingdom, Germany Series A, Series B, Seed Health Care, Medical, Biotechnology
Ersin Pamuksüzer
Angel
2 Turkey, Germany Seed, Series A Education, Life Science, Virtual Reality $300k–$500k
Edward Lando
Angel
2 United States, United Kingdom, France Seed, Pre-Seed, Series A Software, FinTech, Artificial Intelligence $125k–$31M
Mati Staniszewski
Angel
2 United States, United Kingdom, Sweden Seed, Pre-Seed, Series A Artificial Intelligence, Software, Information Technology $2M–$75M
Aidan Gomez
Angel
2 United States, United Kingdom, Canada Seed, Pre-Seed, Series A Artificial Intelligence, Software, Generative AI $1.8M–$12M
Simon Galbraith
Angel
2 Croatia, United Kingdom Seed, Pre-Seed, Venture - Series Unknown Software, Health Care, Life Science
Nadav Ben-Chanoch
Angel
2 United States, France, United Kingdom Seed, Pre-Seed, Series A Software, Information Technology, Artificial Intelligence $120k–$30M
Ed Parkinson
Angel
2 United Kingdom Seed Health Care, Life Science, Biotechnology $1.9M–$3M
Sake Bosch
Angel
1 The Netherlands, France, Israel Seed, Series A, Series B Software, E-Commerce, Biotechnology $1.3M–$77M
David Lucas
Angel
1 United Kingdom Seed Software, Life Science, Biotechnology
Fiona Pathiraja
Angel
1 United Kingdom, Germany, Armenia Seed, Pre-Seed, Series A Health Care, Medical, Software $840k–$13M
Johnathan Matlock
Angel
1 United Kingdom Seed, Venture - Series Unknown, Pre-Seed Medical, Biotechnology, Health Care $1.1M–$6.1M
Jon Oringer
Angel
1 United States, United Kingdom, France Seed, Pre-Seed, Series A Software, Information Technology, Health Care $100k–$31M
Michelle Tempest
Angel
1 United Kingdom Seed, Pre-Seed, Series A Health Care, Biotechnology, Cannabis
Duncan Grierson
Angel
1 United Kingdom Seed, Series A Water, Medical, CleanTech
Amar Shah
Angel
1 United Kingdom, Poland, Germany Pre-Seed, Seed, Angel Artificial Intelligence, Software, Health Care $642k–$15M
Sharaf Yamani
Angel
1 India, United Kingdom Seed Biotechnology, Software, Life Science $900k–$1.4M
Patrick Pichette
Angel
1 United Kingdom, Germany, United States Seed, Series A, Series B Artificial Intelligence, Software, Machine Learning $913k–$95M
Ramesh Haridas
Angel
1 United States, United Kingdom, India Seed, Angel, Pre-Seed Internet, Software, TV $500k–$1.5M
Alvaro Martinez Barrio
Angel
1 United Kingdom Seed Robotics, Biopharma, Life Science
Maximilien Levesque
Angel
1 United Kingdom Seed Life Science, Biotechnology
Will Brooks
Angel
1 United Kingdom, United States Seed, Series A, Venture - Series Unknown Financial Services, FinTech, Software $501k–$30M
Huw Bishop
Angel
1 United Kingdom Angel, Pre-Seed EdTech, Training, E-Learning
John Anthony Knight
Angel
1 United Kingdom Seed Software, Life Science, Biotechnology
Sami Mikati
Angel
1 India, United Kingdom Seed Biotechnology, Software, Life Science $900k–$1.4M
Michail Eleftheriou
Angel
1 United Kingdom Seed Software, Life Science, Biotechnology $150k–$900k
Gordon Ashworth
Angel
1 United Kingdom Seed FinTech, Biopharma, Health Care $653k–$791k
Jim Warwick
Angel
1 United Kingdom Seed Medical, Health Care, Life Science
Will Neale
Angel
1 United Kingdom, Spain, Italy Pre-Seed, Seed Financial Services, FinTech, Software $120k–$6.3M
Margaret Georgiadis
Angel
1 United States, United Kingdom Seed, Series A, Series B Health Care, Apps, Medical $2.3M–$50M
Rick Bernstein
Angel
1 United Kingdom, The Netherlands Seed, Pre-Seed Biotechnology, AgTech, Farming
Ahmet Bilgen
Angel
1 Turkey, United Kingdom, Estonia Seed, Angel, Pre-Seed Software, Education, E-Commerce $50k–$1.2M
Will Martin
Angel
1 United Kingdom, United States, Japan Seed, Series A, Venture - Series Unknown Software, Financial Services, FinTech $874k–$11M
Access all 100 angel investors in United Kingdom Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Jonathan Milner
Angel · Cambridge, Massachusetts, United States · 11 investments in United Kingdom Life Science startups

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Spain

Investor stats

  • Total investments: 63
  • Round size: Seed $537k–$25M; Series A $4.5M–$50M; Series B $1.6M–$56M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
  • Nuclera — Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers. Nuclera's eProtein DiscoveryTM system allows scientists to rapidly produce and test proteins for drug discovery.
  • 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Show all investments...

Nadav Rosenberg
Angel · London, England, United Kingdom · 5 investments in United Kingdom Life Science startups

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, France, Israel

Investor stats

  • Total investments: 16
  • Round size: Seed $1.1M–$3.1M; Pre-Seed $2M–$2M; Series A $18M–$21M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Teora — Crude oil derived products have infiltrated every industry – synthetic colors, flavors, fragrances in food, dyes in textiles, fertilizers and packaging material that harm humans and the planet. TeOra’s mission is to replace synthetics with naturals that are manufactured in a sustainable and predictable manner. A microorganism is the best factory,optimized over billions of years of evolution and TeOra designs it to produce desired products. Using microfluidics and AI, TeOra offers 100 times faster and cheaper design of smart micro-organisms in weeks to months instead of years.
  • thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
  • Lindus Therapeutics — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
Show all investments...

Jeff Dean
Angel · Palo Alto, California, United States · 3 investments in United Kingdom Life Science startups, 20 in the past 12 months

Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 109
  • Round size: Seed $2.5M–$34M; Pre-Seed $500k–$3M; Series A $10M–$60M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Grubel — Grubel envisions a future in which each substance creates its own AI, one that understands its surroundings and performs the best work possible within them.
  • G5 Labs — G5 is the semantic abstraction layer that makes AI-native software development compilable, mergeable, and governable for enterprises.
  • Wafer — Wafer is an AI optimization platform that automatically accelerates AI models by generating efficient custom GPU kernels.
Show all investments...

Stefano Bernardi
Angel · San Francisco, California, United States · 3 investments in United Kingdom Life Science startups

Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.

Show more...

Investment focus

  • Industry: Blockchain, Software, Biotechnology
  • Stage:Seed, Pre-Seed
  • Geography: Italy, United Kingdom, Canada

Investor stats

  • Total investments: 18
  • Round size: Seed $100k–$18M; Pre-Seed $874k–$2.2M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Freatic — Building the monetization layer for your alpha
  • Niulinx — Niulinx specializes in providing autonomous driving technology solutions based on artificial intelligence, connectivity, and data analytics.
  • Automated Architecture — A global ecosystem of automated micro-factories, to deliver sustainable, affordable and beautiful architecture to millions of people.
Show all investments...

Jude Gomila
Angel · San Francisco, California, United States · 3 investments in United Kingdom Life Science startups

Jude Gomila is currently CEO and Founder of the startup Golden.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 67
  • Round size: Seed $1.4M–$4.7M; Angel $70k–$1.3M; Pre-Seed $1M–$2.9M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Clara — Clara is an AI-powered primary care doctor.
  • Dirac Labs — Universal Navigation Powered by Quantum Sensing & AI
  • Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
Show all investments...

Charlie Songhurst
Angel · Greater Seattle Area, Washington, United States · 2 investments in United Kingdom Life Science startups, 25 in the past 12 months

Charles Songhurst is a founding partner of Katana Capital, a long-short equity hedge fund. He also runs the Songhurst Group, which holds assets in a variety of private companies.Charles ran corporate strategy for Microsoft and focused on partnering and M&A. He was involved in the Yahoo acquisition and commercial deal, and the Skypeacquisition. Before running corporate strategy, Charles was focused on the emergence of Google and the growth of the search industry.Prior, Charles was an analyst at McKinsey & Company in London. Charles received a bachelor’s degree from Oxford University in politics, philosophy, and economics.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 258
  • Round size: Seed $1.1M–$8M; Pre-Seed $500k–$5.1M; Series A $2.9M–$24M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Zeit AI — Zeit AI, founded by former Palantir engineers, generates a structured data base atop your tabular data files which you can query using natural language. For example, you suspect an efficiency in your organisation and you have a bunch of data files, instead of reading through all of them one by one in excel, you explore them in Zeit AI. Theycurrently offer a two-week pilot program where their engineers develop tailored solutions for data challenges involving CSV, Excel, or PDF files.
  • Mantic — Mantic is a world-class technical team on a mission to solve the next AI grand challenge: predicting global events with superhuman accuracy, and deploying this capability to power radically improved decision-making in business and government.
  • Pilgrim — Pioneering a biologically enhanced future for humanity.
Show all investments...

Jan Hruska
Angel · Abingdon, Oxfordshire, United Kingdom · 2 investments in United Kingdom Life Science startups

Jan Hruska

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Seed, Venture - Series Unknown
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Show all investments...

Matt Clifford
Angel · London, England, United Kingdom · 2 investments in United Kingdom Life Science startups

Matt co-founded EF after being a consultant at McKinsey & Co. Prior to EF Matt spent his time studying at MIT fuelled by an obsession with R, Python and unusual datasets. EF is the best place for Europe’s top technical individuals to meet and build world-changing startups in London.They select purely on the basis of technical talent, so youcan apply before you have a team or an idea. The intensive 6-month programme is designed to give you the best possible support in the first 200 days of your startup’s life.They have created over 40 startups now worth over $300 million. The startups are funded by some prestigious investors including Balderton Capital, Index Ventures, Octopus Investments and Y Combinator.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, FinTech
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: United Kingdom, United States, India

Investor stats

  • Total investments: 42
  • Round size: Seed $756k–$7M; Pre-Seed $55k–$4.2M; Venture - Series Unknown $2.4M–$34M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Stackfix — Stackfix operates as a software comparison platform.
  • Rivan Industries — Rivan Industries designs and builds modular, vertically integrated, synthetic fuel plants.
  • Asymmetric Security — Asymmetric Security is an AI-native cybersecurity startup specializing in digital forensics and incident response. It combines elite forensic experts with proprietary AI to accelerate investigations, especially Business Email Compromise (BEC) attacks, at less than half the cost of competitors while shrinking timelines from days to hours.
Show all investments...

Paul Forster
Angel · Cambridge, Massachusetts, United States · 2 investments in United Kingdom Life Science startups, 9 in the past 12 months

Paul Forster is an early-stage investor in the tech sector. He previously worked at Indeed as a Senior Advisor. Paul attended INSEAD, where he earned an MBA.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, Germany, United States

Investor stats

  • Total investments: 82
  • Round size: Seed $1M–$6.9M; Pre-Seed $1.1M–$3.5M; Series A $3.7M–$26M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Otel AI — Otel reads every system your hotel runs on as one hotel, then hands your team each decision with the case already made. Live in days.
  • Wassist — Launch your AI sales agent on WhatsApp for Shopify in under 60 seconds. Recover 30-50% of abandoned carts and increase conversions by 3x.
  • Capsa AI — Providing next-generation investors with a competitive edge.
Show all investments...

Robert Kopple
Angel · Los Angeles, California, United States · 2 investments in United Kingdom Life Science startups

Robert C. Kopple is based out of Vancouver, Ontario, and is the Partner of Kopple, Klinger & Elbaz. Robert previously worked at Gelum Resources as a Board of Directors. Robert C. Kopple attended New York University.

Show more...

Investment focus

  • Industry: FinTech, Finance, Life Science
  • Stage:Convertible Note, Venture - Series Unknown
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 3
  • Round size: Venture - Series Unknown $3.3M–$4.8M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Tradier — Tradier brings traders, developers, and partners together with tools, infrastructure, and pricing for trading stocks, options, futures, crypto, and forex, or build on our API.
  • ILC Therapeutics — ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Bradley Horowitz
Angel · Palo Alto, California, United States · 2 investments in United Kingdom Life Science startups

Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 137
  • Round size: Seed $150k–$18M; Pre-Seed $500k–$6.6M; Series A $7.5M–$36M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Audioshake — AudioShake makes audio interactive, customizable, and accessible by using AI to separate sound recordings into their component parts and stems.
  • Catena Labs — Catena is a product studio where we transform complex computing advancements into accessible, practical tools for users and developers. Leveraging AI and web3 technology our aim is to turn innovative ideas into real-world applications that are easy to use.
  • NextSense — Introducing NextSense Smartbuds: EEG-powered earbuds that go beyond sleep tracking. Backed by science, Smartbuds provide real-time insights to help you achieve deeper, more restorative sleep. Comfortable, intuitive, and easy to use, Smartbuds empower you to wake up your best self.
Show all investments...

Paul Wicks
Angel · London, England, United Kingdom · 2 investments in United Kingdom Life Science startups

Paul Wicks, Ph.D., is a strategic advisor and independent consultant who helps digital health and life science companies turn data into evidence, evidence into influence, and influence into impact. He has supported over 40 organizations including AstraZeneca, Ada Health, Biogen, Click Therapeutics, and Woebot.Previously, Paul spent 13 years as VPof R&D at PatientsLikeMe, building one of the world’s largest patient communities and pioneering decentralized trials, digital biomarkers, and real-world evidence. He has authored over 200 peer-reviewed papers and served on editorial boards of journals including the BMJ, Digital Biomarkers, and BMC Medicine.A neuropsychologist by training, Paul completed his Ph.D. at King’s College London and a postdoc on the psychology of Parkinson’s disease. His work has been featured by BBC, CNN, and The New York Times. He was named MIT Technology Review’s “Humanitarian of the Year” in 2011 and is a TED Fellow and FLIER alumnus of the Academy of Medical Sciences. He is an honorary Professor at the University of Birmingham.

Show more...

Investment focus

  • Industry: Software, Wellness, E-Commerce
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Japan

Investor stats

  • Total investments: 17
  • Round size: Seed $3M–$6.6M; Pre-Seed $539k–$1M; Series A $6.7M–$11M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Stelia — Stelia builds distributed AI platforms that scale globally. Research-driven intelligent systems for healthcare, education, and enterprise operations worldwide
  • Epiminds — Epiminds develops multi-agent AI systems to run marketing end-to-end.
  • Scooch — All-in-one subscription to eliminate hassle from your pet healthcare. From online assessment, health tracking and AI assistant to 24/7 vet support and vet-formulated treatments.
Show all investments...

Mark Evans
Angel · London, England, United Kingdom · 2 investments in United Kingdom Life Science startups

Mark is currently a Founding Partner and LP and Investment Committee member at Kindred Capital, a European Seed-Stage Venture fund, based in London. He was a General Partner at Balderton Capital/ Benchmark Europe from 2002 through 2015, and an EIR at Benchmark Capital in 1999/2000.He spent the prior 15 years @ Goldman Sachs, where hewas a General Partner and Management Committee member. He studied Economics at both University of Oxford and Queen's University in Canada.

Show more...

Investment focus

  • Industry: Retail, Fashion, Software
  • Stage:Series A, Seed, Series C
  • Geography: United Kingdom, United States, The Netherlands

Investor stats

  • Total investments: 37
  • Round size: Seed $1.4M–$8M; Series A $3.2M–$24M; Series C $8M–$68M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • ONI — Where are you in your super-resolution journey? ONI is here to support you along your super-resolution journey Answer a few simple questions to discover key resources that can help you make the most of single-molecule imaging technology across a wide range of applications Products Gallery FAQs Subscribe to our mailing list
  • Ufonia — Dora is a clinical AI agent that calls and supports your cataract patients, empowering your ophthalmology practice to scale without compromise on care.
  • Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
Show all investments...

Damien Lane
Angel · London, England, United Kingdom · 2 investments in United Kingdom Life Science startups

Damien Lane has spent the last 20 years investing in private companies, both in Private Equity where he was a partner with Electra Partners, then at Octopus Ventures where he was a senior member of the investment team. Having made a number of angel investments, Damien co-founded Episode 1 with Simon and Adrian in 2012. While at Episode 1,Damien has led investments in Carwow, Scurri, Touch Surgery, Attest and Zipcube and loves working with early stage teams of entrepreneurs; helping them develop their early stage startup into a fast growth enterprises capable of raising more funding from later stage investors. When he is not trying to help businesses to implement an optimal approach to growth, Damien can mostly be found running around Hampstead Heath or the Coastal paths of Great Britain. Having trained obsessively to run a 2:52 Marathon in 2015, he is now trying to dip below 2:50, in the spirit of continuous improvement. Damien has an MBA from Cambridge University and a Masters degree in PE from Oxford University.

Show more...

Investment focus

  • Industry: Software, SaaS, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 39
  • Round size: Seed $532k–$3.1M; Pre-Seed $660k–$1M; Series A $3.2M–$16M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • Narchie — Create a home that's uniquely yours with Narchie. Shop sustainably, minimize waste, and find one-of-a-kind homeware items.
  • Surgery Hero — We combine expert human care, individually-tailored content and cutting edge tech to empower people to take control of their health so they can conquer their surgery.
  • Surgery Hero — We combine expert human care, individually-tailored content and cutting edge tech to empower people to take control of their health so they can conquer their surgery.
Show all investments...

Nicholas Edwards
Angel · Oxford, Oxfordshire, United Kingdom · 2 investments in United Kingdom Life Science startups

Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Seed, Venture - Series Unknown
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Show all investments...

Darrin Disley
Angel · Cambridge, Cambridgeshire, United Kingdom · 2 investments in United Kingdom Life Science startups

Darrin Disley is based out of Cambridge, Cambridgeshire, and is the Executive Chairman and Director of Cardiogeni. Darrin previously worked at Mogrify as Chief Executive Officer, Director, and Investor. Darrin Disley attended the University of Cambridge.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Big Data
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: United Kingdom

Investor stats

  • Total investments: 5
  • Round size: Seed $462k–$3.7M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • bit.bio — Bit.bio provides engineered human cell products and platform services for biomedical research, drug discovery, and cell therapy development. The company uses a precision cell programming system to convert stem cells into defined human cell types and supplies a portfolio of reprogrammed cells, custom cell development services, and research-readyhuman cell models for scientific and pharmaceutical use. Bit.bio also supports integration of its products into partner research ecosystems and offers platform capabilities that help identify transcription factors for specific cell states. Its focus includes enabling scalable access to human cell models for experiments, screening workflows, and therapeutic investigation.
  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Show all investments...

Ian Hogarth
Angel · London, England, United Kingdom · 2 investments in United Kingdom Life Science startups

Ian Hogarth is based out of London, England, and is the Chairman of Phasecraft. Ian previously worked at Songkick as a Chairman. Ian Hogarth attended the University of Cambridge.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 62
  • Round size: Seed $1.7M–$14M; Pre-Seed $698k–$7.5M; Series A $11M–$43M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
  • Cordless — Bridging the gap between voice and text
  • Fabric — Fabric is an AI-powered workspace and file manager for people and groups.Fabric is a self-organizing multiplayer workspace.
Show all investments...

Tim Davis
Angel · Santa Monica, California, United States · 2 investments in United Kingdom Life Science startups

Timothy T Davis, MD is Board Certified in Physical Medicine and Rehabilitation (Physiatry) and Pain Medicine. The founder of Source Healthcare, Source Surgery Center, Alpha Diagnostics and he is an expert in spine and musculoskeletal disorders as well as interventional pain management to treat neck, back and sports injuries. Dr. Davis hasperformed extensive clinical research using biological therapies such as stem cells and other biologics for spine and joint injuries. He has consulted and invested in SaaS, medical device, biologics, cannabis, and psychedelics sectors.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 10
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Bryn Pharma — Bryn Pharma is a pharmaceutical company that offers nasal-based epinephrine for anaphylaxis. Its bi-dose intranasal device is an alternative to epinephrine auto-injectors and is needle-free. It is easy to use and portable enabling patients to treat allergic reactions or anaphylactic reactions.
  • Beckley Psytech — Our mission is to help people suffering from neurological and psychiatric conditions by developing our pipeline of psychedelic compounds.
  • MycoMedica Life Sciences, PBC — Psychedelic Medicines
Show all investments...

Ersin Pamuksüzer
Angel · Bodrum, Mugla, Turkey · 2 investments in United Kingdom Life Science startups

Ersin Pamuksüzer

Show more...

Investment focus

  • Industry: Education, Life Science, Virtual Reality
  • Stage:Seed, Series A
  • Geography: Turkey, Germany

Investor stats

  • Total investments: 5
  • Round size: Seed $300k–$500k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Aposto — All-in-one media service currently based in Istanbul, Turkey.
  • VRLab Academy — VRLab Academy | Virtual Experiments
Show all investments...

Edward Lando
Angel · San Francisco, California, United States · 2 investments in United Kingdom Life Science startups

Edward Lando is the founder of Pareto Holdings. He previously worked at Horizons School of Technology as a co-founder. Edward Lando attended the Wharton School.

Show more...

Investment focus

  • Industry: Software, FinTech, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 581
  • Round size: Seed $950k–$6.3M; Pre-Seed $125k–$3.3M; Series A $5M–$31M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Humera — Humera - AI CAPTCHA That Knows You're Human
  • Allonic — Allonic is a robotics hardware company pioneering 3D Tissue Braiding, a new manufacturing platform for producing integrated, compliant, bio-inspired robotic bodies through a single, fully automated production process. By eliminating assembly-heavy designs and supply-chain complexity, Allonic enables significantly faster iteration, lower costs, andsafer, more dexterous robots to be built. Originally founded from Hungary and operating internationally with a US HQ and a growing team of 15, Allonic is building the hardware foundation for the next generation of intelligent machines.
  • Heywa Labs — Two products, one engine. Heywa Studio for businesses, Heywa for anyone with a question worth following.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Mati Staniszewski
Angel · London, England, United Kingdom · 2 investments in United Kingdom Life Science startups, 15 in the past 12 months

Mati Staniszewski is the Co-Founder of ElevenLabs.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Sweden

Investor stats

  • Total investments: 22
  • Round size: Seed $4.5M–$11M; Pre-Seed $2M–$20M; Series A $16M–$75M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • imagi — Programming has never been this much fun! Learn to create with code, share your designs with friends on the imagiLabs app and customize your imagiCharm - a fun, easy-to-use, colorful, and educational toy for girls. Imagine it. Code it. Wear it.
  • Dwelly — Dwelly acquires and partners with independent UK lettings agencies, helping owners exit smoothly, profitably and on their terms. Get a free agency valuation.
  • Arrakis Security — Secure the enterprise agents where they're deployed. Total visibility, governance, and remediation for the autonomous workforce.
Show all investments...

Aidan Gomez
Angel · Oxford, Arkansas, United States · 2 investments in United Kingdom Life Science startups

Aidan Gomez is based out of Toronto, Ontario and is the co-founder & CEO at Cohere. Aidan Gomez attended the University of Oxford.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Generative AI
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 17
  • Round size: Seed $2.8M–$12M; Pre-Seed $1.8M–$3.5M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Cheiron — Cheiron is a domain-tuned AI engine for biomedical and pharmaceutical professionals, delivering fast, verifiable, and context-aware insights across research, clinical, medical affairs, and regulatory workflows.
  • Helical — The full power of DNA & (m)RNA Bio Foundation Models in one open-core platform. Accelerate Drug Discovery with AI.
  • General Magic — General Magic helps insurance teams handle every customer conversation, underwriting decision, and quote in one place. AI built for the way brokerages actually work, deployed inside the systems your team already uses.
Show all investments...

Simon Galbraith
Angel · Cambridge, Cambridgeshire, United Kingdom · 2 investments in United Kingdom Life Science startups

Simon is the joint founder and CEO of Redgate Software. Over the past 15 years, Simon has been part of Redgate’s growth from a 2 person firm operating out of a spare room to today’s 300 person outfit with hundreds of thousands of users. Although Simon’s responsibilities are primarily strategic, his background is technical with qualificationsincluding a PhD in physics from Cambridge University and former employment with Shell and ThornEMI.

Show more...

Investment focus

  • Industry: Software, Health Care, Life Science
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: Croatia, United Kingdom

Investor stats

  • Total investments: 3
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • BoobyBiome — BoobyBiome harnesses breast milk microbiome science to develop products to improve infant health
  • Syskit — Syskit Point keeps your Microsoft 365 environment under control - secured, cost-optimized, and AI confident.
Show all investments...

Nadav Ben-Chanoch
Angel · Miami, Florida, United States · 2 investments in United Kingdom Life Science startups

Nadav Ben-Chanoch

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, France, United Kingdom

Investor stats

  • Total investments: 232
  • Round size: Seed $500k–$6M; Pre-Seed $120k–$2.5M; Series A $4M–$30M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Swaap — We build & operate onchain trading systems. We are a group of scientists and technologists committed to build open systems.
  • micro1 — We help companies hire and manage the best software engineers easily.
  • Skedway — Skedway connects software, AI, sensors, displays and automation into one intelligent operational layer for the physical workplace.
Show all investments...

Ed Parkinson
Angel · 2 investments in United Kingdom Life Science startups

Ed Parkinson

Show more...

Investment focus

  • Industry: Health Care, Life Science, Biotechnology
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Round size: Seed $1.9M–$3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Antiverse — Designing biologics for 100 challenging targets
Show all investments...

Sake Bosch
Angel · Amsterdam, Noord-Holland, The Netherlands · 1 investments in United Kingdom Life Science startups

Sake Bosch is a Founder and Managing Partner of Prime Ventures since 1999. Sake brings over 25 years of experience in marketing and sales and venture capital to Prime. Prior to founding Prime in 1999, Sake was a Senior Principal at Holland Venture and was responsible for managing investments in technology companies. Sake was involved in many ofthe Holland Venture technology investments including Applicare Medical Imaging (acquired by GE Medical Systems), BWise (acquired by Nasdaq), SQL Systems (acquired by Datastream) and Freecom (acquired by Mitsubishi Kagaku Media). Before joining Holland Venture in 1994, Sake worked as an Independent Corporate Finance Consultant focusing primarily on early stage companies. Prior to this position Sake was a Sales Executive at Securitas Group. Sake started his career in 1989 as a Strategic Market Analyst at VNU. Sake serves on the board of directors of Civolution, 4C, Dealerdirect, Digital Origin, Greetz, Forcare, SaaSPlaza, SlimPay and Takeaway.com. Previous investments include: 3mensio Medical Imaging (acquired by Esaoto), eBuddy (acquired by Booking.com), Global Collect (acquired by General Atlantic), MarketXS (acquired by Markit), Nedstat (acquired by comScore Inc.), Tridion (acquired by SDL) and Watermark (acquired by Qurius). Sake holds an M.Sc. degree in Business Administration as well as a B.A. degree in Management Science and Industrial Engineering.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: The Netherlands, France, Israel

Investor stats

  • Total investments: 33
  • Round size: Seed $1.3M–$7.2M; Series A $6.9M–$29M; Series B $7.1M–$77M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • Alfa AI — Alfa AI is a recruitment technology company specializing in AI-driven hiring solutions.
  • TerraSpark — TerraSpark Energy specializing in software solutions for renewable energy asset management. The product, TerraSpark Hub, provides comprehensive oversight of commercial and technical data for green energy assets like solar and wind projects.
  • Recupere Metals — Recupere Metals focused on recycling copper scrap into high-quality electrical wires. It uses a patented mechanical process enhanced by AI to boost conductivity from impure scrap, bypassing energy-intensive smelting.
Show all investments...

David Lucas
Angel · 1 investments in United Kingdom Life Science startups

David Lucas

Show more...

Investment focus

  • Industry: Software, Life Science, Biotechnology
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Show all investments...

Fiona Pathiraja
Angel · 1 investments in United Kingdom Life Science startups

Fiona is Managing Partner at Crista Galli Ventures, an early stage healthtech VC fund based in London and Copenhagen.

Show more...

Investment focus

  • Industry: Health Care, Medical, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, Germany, Armenia

Investor stats

  • Total investments: 15
  • Round size: Seed $1.1M–$4.5M; Pre-Seed $840k–$2.5M; Series A $10M–$13M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Unfabled — Menstrual care and wellness products for your cycle. Organic period products in sustainable packaging. Curated brands for skincare, sleep, cravings, cramping, mood swings, and relaxation. For all your self-care needs, we have you covered.
  • Bloom Money — Bloom Money is a savings club app designed to help growing communities in migrant communities and use technology to promote community, safety, and convenience.
  • Everyman Health — Everyman Health ist Spezialist für Männergesundheit und bietet wissenschaftlich fundierte Lösungen für Männer aller Altersgruppen. In Zusammenarbeit mit unseren Partnern, bieten wir dir ein umfassendes Portfolio von digitalen, medikamentösen und nicht-medikamentösen Therapien für unterschiedliche Männerprobleme.Über unsere Plattform wirst du inwenigen Minuten mit einem Schweizer Facharzt verbunden und erhältst eine persönliche Diagnose und gegebenenfalls ein Rezept.Auf Wunsch wird deine persönliche Behandlung von einer lizenzierten Schweizer Apotheke diskret verpackt und dir kostenlos bis vor die Haustür geliefert.
Show all investments...

Johnathan Matlock
Angel · Bedford, Bedfordshire, United Kingdom · 1 investments in United Kingdom Life Science startups

Johnathan Matlock is Co-Founder Science Angel Syndicate.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Seed, Venture - Series Unknown, Pre-Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 15
  • Round size: Seed $1.3M–$6.1M; Pre-Seed $1.1M–$1.1M; Venture - Series Unknown $2.3M–$6M
  • Lead/follow: 53% lead, 47% follow

Portfolio highlights

  • Caudal Energy — Porpoise Power develops a tidal energy system using oscillating hydrofoil technology inspired by dolphin swimming mechanics.
  • Halo Therapeutics — Halo Therapeutics is based in England. Develops safe pan coronavirus antiviral drugs for Covid-19 that can be administered by patients.
  • QV Bioelectronics — Time is precious and for patients with the most common brain tumour, glioblastoma, the value of that time really comes into focus when they are suddenly hit with the news there is no cure and that they have just one year to live. Current treatment options are not good enough and come at a huge cost to the quality of that remaining time. Ourco-founder Dr Richard Fu recognised this and was frustrated not only by the lack of treatments available for his brain tumour patients but also by major design flaws in newer electrotherapy approaches. Working together with Dr Chris Bullock, a biomedical engineer arising from Manchester's world-class materials research centres, they formed an elegant solution designed to optimise patient life-expectancy and quality of life. Together they formed QV Bioelectronics, and since then, their ground-breaking research has received over $425k in financial awards from several UK institutions, including Innovate UK and the National Institute for Health Research in the UK. The technology core patent has been filed, with full FTO. Additionally, alongside Dr Fu's expertise, the clinical advisory board contains some of Britain's top neurosurgeons who are helping to input into the feedback of the technology design. Our aim is to double patient life expectancy compared to standard treatment without impacting quality of life, so patients can focus on what matters. Join us at QV Bioelectronics, in pioneering a better option for terminal cancer patients.
Show all investments...

Jon Oringer
Angel · Miami, Florida, United States · 1 investments in United Kingdom Life Science startups

Jon Oringer is the founder and chairman of Shutterstock.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 140
  • Round size: Seed $600k–$5.5M; Pre-Seed $100k–$3.3M; Series A $4M–$31M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • SLUSHY — SLUSHY is a secure mobile web based platform for content creators to find, grow, & monetize their audiences. A creator first, tech-driven tool, designed with key discoverability features and audience insights. In a market where existing solutions (OnlyFans, Patreon) fall short of their creators' demands, SLUSHY provides an alternativesolution for professional content creators that prioritizes their monetization, support and management needs. SLUSHY incorporates a powerful legal framework, with robust compliance tools including simplified consent, ID verification, and content moderation. The new home of unrestricted content, SLUSHY is here.
  • Unsloth AI — Unsloth is an open-source, no-code web UI for training, running and exporting open models in one unified local interface.
  • OneImaging — OneImaging makes life-saving diagnostics affordable, accessible, and personal. We connect employers, health plans, and members to a trusted national network of imaging centers, delivering faster answers with transparent pricing and premium care across MRIs, CT scans, ultrasounds, mammograms, X-rays and more. We serve organizations looking to control medical spend and individuals who need reliable results without delays. Every scan booked through OneImaging is proof that healthcare can be simpler, cheaper, and kinder.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Michelle Tempest
Angel · 1 investments in United Kingdom Life Science startups

Michelle Tempest

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Cannabis
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 4
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Daye — Daye has set out to build a new brand for female health products “designed with women in mind.” The startup’s first product is a newly developed tampon that uses CBD to help tackle period cramps (or dysmenorrhea) as an alternative to traditional painkillers (CBD is the extract derived from the flower of the industrial hemp plant, a legal relativeto marijuana).
  • Sanome — Sanome are combining different types of biomarkers to develop engaging, useful and accurate diagnostic products (IVDs) that enable early detection and prevention of disease. The IVD innovation engine, will ultimately enable new approaches for healthcare delivery, providing access to novel at-home testing paradigms for all people.
  • Medwise.ai — Medwise.ai is the Google for doctors.
Show all investments...

Duncan Grierson
Angel · 1 investments in United Kingdom Life Science startups

Duncan Grierson

Show more...

Investment focus

  • Industry: Water, Medical, CleanTech
  • Stage:Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Puraffinity — Puraffinity develops targeted materials for water treatment, focused on forever chemicals called PFAS. Our strategic intent is to provide 1 billion people with PFAS safe water by 2030
  • Moixa Technology — Moixa Technology develops the Maslow intelligent energy storage solution, enabling homes to store energy and benefit from revenue streams generated by trading energy through GridShare, an SaaS platform that aggregates energy from groups of Maslow energy storage systems. . The company develops smart DC technologies to power DC lighting, computing,electronics from grid-shifted storage or local PV from smart DC hubs, variable DC networks and sockets. The technology and IPR reduces grid peak by shifting DC device load and powering DC devices efficiently without inverters or AC/DC adaptors, together with providing smart control and energy management. The technology aims to address the 1 trillion kwh + lost annually in power conversion, and the significant growing DC demand in homes, offices from ICT, LED lighting and the rise in internet connected devices.
Show all investments...

Amar Shah
Angel · San Diego, California, United States · 1 investments in United Kingdom Life Science startups

Amar Shah is based out of London and is the Founder & Partner of Dhyan VC. Amar previously worked at Firstminute Capital as an Entrepreneur In Residence. Amar Shah attended the University of Cambridge.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Pre-Seed, Seed, Angel
  • Geography: United Kingdom, Poland, Germany

Investor stats

  • Total investments: 10
  • Round size: Seed $4.8M–$15M; Pre-Seed $642k–$2.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • sensmore — Equip your machinery with autonomy built for the harshest conditions. Enhance safety, reduce costs, and increase efficiency with our advanced radar technology.
  • ReSpo.Vision — Enhance your sports analytics and visualise the game using AI & Computer Vision-powered Sports Tracking and Event Data.
  • TextCortex — Create the highest quality content 7x faster, using TextCortex AI - the best copywriting tool for all your content. Get started for free, no credit card required.
Show all investments...

Sharaf Yamani
Angel · London, England, United Kingdom · 1 investments in United Kingdom Life Science startups

Sharaf Yamani - Managing Director @ Windlesham Advisors

Show more...

Investment focus

  • Industry: Biotechnology, Software, Life Science
  • Stage:Seed
  • Geography: India, United Kingdom

Investor stats

  • Total investments: 2
  • Round size: Seed $900k–$1.4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • CyGenica — CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics.
  • Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Show all investments...

Patrick Pichette
Angel · London, England, United Kingdom · 1 investments in United Kingdom Life Science startups

Patrick Pichette is based out of London, England, and is the Partner of Inovia Capital and also Board Member of Cohere. Patrick Pichette previously worked at Twitter as a Board of Directors. Patrick Pichette attended the University of Oxford.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Machine Learning
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, Germany, United States

Investor stats

  • Total investments: 27
  • Round size: Seed $913k–$10M; Series A $10M–$95M; Series B $15M–$95M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Mobai — Provider of attack detection, image manipulation detection and authentication. Strong and successful research team on biometrics.
  • Kaedim — AI-powered 3D asset creation service delivering fast, production-ready 3D assets. Scale 3D pipelines without hiring, accelerate 3D game art production, and reduce 3D asset costs by up to 90%.
  • Clove — Building the financial institution of the future, to make money make sense.
Show all investments...

Ramesh Haridas
Angel · New York, New York, United States · 1 investments in United Kingdom Life Science startups

Ramesh Haridas is an Angel Investor since June 2006. Ramesh has been an entrepreneur and an investor in early stage internet companies for the last 10 years. He has started and sold two internet companies. Ramesh was Co-Founder and Chief Executive Officer at Parakweet from March 2010 to February 2016. Parakweet is Ramesh's third startup.Ramesh has started and successfully sold two internet companies before - PrivacyBank.com, an online information bank; and Chintano -- an internet ad network that built proprietary contextual and behavioral targeting technology. Ramesh is also an active angel investor and was the first angel investor in 8tracks, nRelate (sold to IAC), and Esaya (sold to Linkedin); and an early investor in Mashery, AVG and Rapportive. In his free time, he enjoys playing squash and discovering good fiction. Ramesh holds a B.S. degree in Computer Science from the University of Illinois at Urbana Champaign.

Show more...

Investment focus

  • Industry: Internet, Software, TV
  • Stage:Seed, Angel, Pre-Seed
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 10
  • Round size: Seed $500k–$1.5M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Ryde — Ryders is a last-mile delivery business that puts people and planet first.
  • Sano Genetics — Sano Genetics is a health technology company that focuses on personalized medicine and genetics. They aim to empower individuals to contribute their genetic and health data for research purposes, with the goal of advancing scientific understanding and personalized approaches to healthcare. Sano Genetics often operates within the context of geneticresearch studies and projects, allowing participants to share their genetic information to contribute to the broader field of medical research
  • Carv — Improve your skiing technique with real-time audio coaching. Carv uses pressure and motion analysis to score your technique and help you improve.
Show all investments...

Alvaro Martinez Barrio
Angel · Uppsala, Uppsala Lan, Sweden · 1 investments in United Kingdom Life Science startups

Alvaro Martinez Barrio is aCTO at Pixelgen Technologies, Life Sciences & Technology Advisor, and Investor.

Show more...

Investment focus

  • Industry: Robotics, Biopharma, Life Science
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Multus — Key ingredients for the affordable scale-up of cellular agriculture
Show all investments...

Maximilien Levesque
Angel · Paris, Ile-de-France, France · 1 investments in United Kingdom Life Science startups

Maximilien Levesque - CEO and co-founder @ AQEMIA

Show more...

Investment focus

  • Industry: Life Science, Biotechnology
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • CardiaTec Biosciences — CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery to deliver the next generation of therapeutics
Show all investments...

Will Brooks
Angel · London, England, United Kingdom · 1 investments in United Kingdom Life Science startups

Will Brooks - Founder & Director @ Portfolio Ventures

Show more...

Investment focus

  • Industry: Financial Services, FinTech, Software
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 72
  • Round size: Seed $501k–$3.5M; Series A $2.2M–$30M; Venture - Series Unknown $1.6M–$2.7M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Bequest — Digital estate planning made easy for professionals and individuals. Securely protect online accounts, cryptocurrencies, emails, media, documents and more.
  • Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
  • Robin — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.
Show all investments...

Huw Bishop
Angel · Wales, Cumbria, United Kingdom · 1 investments in United Kingdom Life Science startups

Huw Bishop is an individual investor.

Show more...

Investment focus

  • Industry: EdTech, Training, E-Learning
  • Stage:Angel, Pre-Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • 10six Games —
  • clear_pixel VR — We build VR and AR training platforms and product demonstrations for education and enterprise.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
John Anthony Knight
Angel · 1 investments in United Kingdom Life Science startups

John Anthony Knight

Show more...

Investment focus

  • Industry: Software, Life Science, Biotechnology
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Show all investments...

Sami Mikati
Angel · 1 investments in United Kingdom Life Science startups

Sami Mikati is a Director of Synthace Ltd. Investor and commercial executive with deep experience and network across energy and engineering industries in Europe, the Middle East and Africa.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Life Science
  • Stage:Seed
  • Geography: India, United Kingdom

Investor stats

  • Total investments: 2
  • Round size: Seed $900k–$1.4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • CyGenica — CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics.
  • Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Show all investments...

Michail Eleftheriou
Angel · London, England, United Kingdom · 1 investments in United Kingdom Life Science startups

Michail Eleftheriou

Show more...

Investment focus

  • Industry: Software, Life Science, Biotechnology
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Round size: Seed $150k–$900k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
  • 2Go Mobile Now — Creators of 2Go, an example of Enterprise Applications Mobility Layer (EnAML) solutions to mobilise enterprise applications in moments whilst fully data secure.
Show all investments...

Gordon Ashworth
Angel · London, England, United Kingdom · 1 investments in United Kingdom Life Science startups

Gordon Ashworth

Show more...

Investment focus

  • Industry: FinTech, Biopharma, Health Care
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Round size: Seed $653k–$791k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Credit Kudos — Credit Kudos builds products using Open Banking so credit providers can approve more people and lower risk. Explore now!
  • Sano Genetics — Sano Genetics is a health technology company that focuses on personalized medicine and genetics. They aim to empower individuals to contribute their genetic and health data for research purposes, with the goal of advancing scientific understanding and personalized approaches to healthcare. Sano Genetics often operates within the context of geneticresearch studies and projects, allowing participants to share their genetic information to contribute to the broader field of medical research
Show all investments...

Jim Warwick
Angel · Cambridge, Cambridgeshire, United Kingdom · 1 investments in United Kingdom Life Science startups

Jim started work at Analysys Limited, a Cambridge-based telecommunications consultancy, heading up its IT, software and web development initiatives. Jim then joined Abcam as a Technical Director, and took over the operational management of the UK office as Managing Director in June 2004, working on both cost saving and efficiency improvementprojects. In 2009, Jim became Chief Operating Officer, with the responsibility for overseeing the operational strategy of the Group. Jim is a Director of Chesterton Community College, Chesterton Sports Centre Limited and Cambridge Nutraceuticals Limited. He has also taken up a non-executive position at Quartix Holdings Plc. Jim had over 15 years’ experience in developing and implementing IT systems and strategy before moving into a broader operational management role within Abcam.Here his skills have been particularly focused on developing a scalable operating model for Abcam which, supported by IT systems, has underpinned Abcam’s rapid growth over the past decade.

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Qkine — Growth Factors made for stem cells Animal-free We control every step of protein manufacture ensuring all our products are completely animal-free Total transparency Stringent purity and bioactivity testing data for all proteins - know what you are giving your cells Protein innovation Our R&D team
Show all investments...

Will Neale
Angel · London, England, United Kingdom · 1 investments in United Kingdom Life Science startups

Founder (Grabyo, Fonix). Investor.

Show more...

Investment focus

  • Industry: Financial Services, FinTech, Software
  • Stage:Pre-Seed, Seed
  • Geography: United Kingdom, Spain, Italy

Investor stats

  • Total investments: 57
  • Round size: Seed $120k–$6.3M; Pre-Seed $650k–$3.7M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • qomodo — Qomodo: La piattaforma BNPL innovativa. Rate a tasso zero, approvazioni veloci, transazioni sicure. Rivoluzionaria nell'acquisto per aziende e consumatori.
  • Verisian — Verisian accelerates drug time to market with the industry's first platform offering real study traceability (CDISC, SDTM, ADaM, TFLs)
  • SAPI — SAPI builds credit products for payment companies to facilitate payment flows, engage and retain merchants, and generate new revenue.
Show all investments...

Margaret Georgiadis
Angel · San Francisco, California, United States · 1 investments in United Kingdom Life Science startups

Margaret Georgiadis is based out of Cambridge, Massachusetts and is the Co-founder and CEO of Montai Therapeutics. Margaret previously worked at Ancestry as a President and CEO. Margaret Georgiadis attended Harvard Business School. Margaret Georgiadis has received the Excellence Award in Innovation.

Show more...

Investment focus

  • Industry: Health Care, Apps, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 15
  • Round size: Seed $2.3M–$5.8M; Series A $11M–$50M; Series B $20M–$24M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • OneRoof — OneRoof is an app that helps meet people with similar interests living in your building and build new friendships. Communication should go further than a nod in the elevator.
  • ShareWell — Discover a supportive mental health community with peer-led sessions, expert insights, and helpful resources to guide your healing journey.
  • Bridge Money — Bridge is a seed stage fintech startup, built to empower members to make more money.
Show all investments...

Rick Bernstein
Angel · North Myrtle Beach, South Carolina, United States · 1 investments in United Kingdom Life Science startups

Rick Bernstein is the Chief Commercial Officer for MedNet responsible for the development of the commercial infrastructure and strategy for MedNet, a healthcare technology company specializing in eClinical solutions for the global life sciences industry. Rick is currently leading the development of an optimized sales, business development, anddistribution strategy to drive aggressive growth across key market segments, including CROs and pharmaceutical, medical device and biotechnology sponsors.

Show more...

Investment focus

  • Industry: Biotechnology, AgTech, Farming
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, The Netherlands

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Farmless — A farmless fermentation platform has the potential to create an entirely new food repertoire, producing proteins, carbohydrates, beneficial fats, vitamins, and minerals from the ground up," explained Oner. "We are creating a new interface between food and electricity by domesticating microbes chosen for their food properties and abilityto grow on renewable energy-based feedstocks.
  • Phytoform Labs — Phytoform Labs is improving crops to make agriculture more sustainable and nutritious
Show all investments...

Ahmet Bilgen
Angel · Istanbul, Istanbul, Turkey · 1 investments in United Kingdom Life Science startups

Ahmet Bilgen Turkish Cypriot entrepreneur and angele investor. He lives in Famagusta-North Cyprus. He finished primary school and high School in Famagusta. He has been a very active person all throughout his life, he received a Black Belt II. Dan in TaeKwon-do, played in the local soccer team while studying at Canbulat high school. Ahmet was alsohelping his family with their farming business by selling the produce to shops, making some money in the meanwhile which he used to buy his first bicycle, first ball or his first pair of sneakers. Ahmet graduated with Bsc in Applied Marth and Computer Science from Eastern Mediterranean University (EMU) in 1993. Between 1993 and 1995 he got his Masters degree in Computer Science. Right after he started his PhD degree in Computer Science but decided to quit academia after his first semester. During his masters and PhD degrees, he took part in developing intelligent user interfaces and inmemory data concepts for mobile devices. After leaving academic life, Ahmet worked in various IT companies for about 2 years and then joined SAP where he had his first professional work experience. Ahmet joined SAP Turkey as the Technology Consultant, and therefore took part in the implementation of more than 100 SAP projects with companies like Yaşar, Koç, Sabancı, Havelsan, Arena etc. as these were the first implementers of SAP ERP in Turkey. During his tenure at SAP, he worked in various roles such as technical consultant, business analyst, project and team manager and architect. Ahmet, after working at SAP for 2 years and getting enough project experience and honing on his technical skils, he decided to set up FIT “Future Information Technology” Solutions together with 3 of his friends in 1999. By the end of 1999 FIT had already made its first million USD revenue. FIT has integrated Turkey’s most important e-commerce platform named “Arena Computer Supplier Portal” with SAP. This was featuted as an international success story by SAP Inside magazine in 2001. FIT Solutions(lately became Foriba) has a lot of experience from completing many software integration projects. Working with the top 250 companies also gives the company the advantage to have a more extensible, scalable, sustainable and supportable product. These experiences and know-how attained over the years put the company in an advantageous position to achieve end-to-end e-invoicing solutions. in 2019 Ahmet Bilgen exited from Foriba. Foriba did: - Series A With Revo Capital - Series B With Revo, IFC, Endeavor Catalyst - Exit

Show more...

Investment focus

  • Industry: Software, Education, E-Commerce
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Turkey, United Kingdom, Estonia

Investor stats

  • Total investments: 17
  • Round size: Seed $250k–$1.2M; Angel $74k–$140k; Pre-Seed $50k–$250k
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • FlexyWatt — FlexyWatt provides a dedicated solution for energy management systems.
  • Topi — Topi is an B2B e-commerce platform for wholesale market.
  • admarket.co — Admarket is a trailblazing AdTech startup that's reshaping the advertising landscape. By offering a streamlined and secure platform for reserving, purchasing, and selling ad spaces, it connects advertisers and media owners like never before. With just one click, advertisers can book various types of ad spaces - including TV, radio, digitalscreen, outdoor, in-store, and in-flight - from anywhere in the world.Admarket simplifies the process of securing ad spaces from preferred media owners and agencies, while its payment service provider, Stripe, ensures top-notch security for customer credit card information. Media owners benefit by gaining access to a global customer base and boosting their revenue.Designed for ease of use, Admarket allows advertisers to view ad spaces on a map, similar to hotel booking sites. Its innovative AdsChange feature enables media owners to swap ad spaces with one another, like exchanging billboard space for radio ads. Plus, advertisers can swiftly broadcast urgent announcements via TV or radio.Looking ahead, Admarket aims to leverage AI technology for identifying sector-specific advertising needs, planning, and design. It will also incorporate automatic bid strategies for outdoor media, TV, and radio ad spaces. Advertisers will be able to view cost-effective advertising options on various timeframes through chart data, akin to flight ticket pricing. Moreover, the AdBroker feature will enable media owners to earn additional income through Admarket's profit-sharing program.In a nutshell, Admarket is a groundbreaking AdTech startup that's revolutionizing the advertising industry by streamlining ad space booking for advertisers and expanding the customer base for media owners. With plans to introduce even more cutting-edge features, Admarket will continue to drive innovation for both advertisers and media owners.
Show all investments...

Will Martin
Angel · London, England, United Kingdom · 1 investments in United Kingdom Life Science startups

Will Martin - Founder and Director @ Portfolio Ventures

Show more...

Investment focus

  • Industry: Software, Financial Services, FinTech
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: United Kingdom, United States, Japan

Investor stats

  • Total investments: 107
  • Round size: Seed $874k–$5.5M; Series A $2.3M–$11M; Venture - Series Unknown $1.5M–$6.6M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Bequest — Digital estate planning made easy for professionals and individuals. Securely protect online accounts, cryptocurrencies, emails, media, documents and more.
  • Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
  • Robin — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.
Show all investments...

Life Science Angel investor funding in United Kingdom at a glance

Stats across 80 deals from 100 investors.

100
investors
in United Kingdom Life Science startups
80
deals
in United Kingdom Life Science startups
$2.6M
median round
in United Kingdom Life Science startups
6%
lead investors
lead at least one round
46%
Seed
most common funding stage

Access all 100 angel investors in United Kingdom Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Angel Investors in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 100 angel investors investing in United Kingdom Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists